Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma

Jeayeon Park, Sung Won Chung, Yun Bin Lee, Hyunjae Shin, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jeonghwan Youk, Ji Yun Lee, Jeong-Ok Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae Min Kim, Jeong-Hoon Lee

Clin Mol Hepatol. 2023;29(3):794-809. Published online May 17, 2023

DOI: https://doi.org/10.3350/cmh.2023.0057

View: 3103 Download: 132 Web of Science: 1 Crossref: 1

Editorial

What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?

Min Kyung Park, Yoon Jun Kim

Clin Mol Hepatol. 2023;29(2):332-334. Published online March 16, 2023

DOI: https://doi.org/10.3350/cmh.2023.0080

View: 2342 Download: 47

Original Article

Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study

Moon Haeng Hur, Dong Hyeon Lee, Jeong-Hoon Lee, Mi-Sook Kim, Jeayeon Park, Hyunjae Shin, Sung Won Chung, Hee Jin Cho, Min Kyung Park, Heejoon Jang, Yun Bin Lee, Su Jong Yu, Sang Hyub Lee, Yong Jin Jung, Yoon Jun Kim, Jung-Hwan Yoon

Received January 20, 2024 Accepted May 9, 2024

DOI: https://doi.org/10.3350/cmh.2024.0055 [Accepted]

View: 138 Download: 17

1 |

Viewed By 5853	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5179	MAFLD: How is it different from NAFLD?
Viewed By 4904	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3999	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 3982	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 136	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 104	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 82	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 71	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 63	MAFLD: How is it different from NAFLD?

Search